Literature DB >> 33100423

Occupational team safety in ECT practice during the COVID-19 pandemic.

Renato Ferreira Araujo1, Lucio de Oliveira Quites1.   

Abstract

Entities:  

Year:  2020        PMID: 33100423      PMCID: PMC7574897          DOI: 10.1016/j.bjane.2020.08.010

Source DB:  PubMed          Journal:  Braz J Anesthesiol        ISSN: 0104-0014


× No keyword cloud information.
Dear Editor, Electroconvulsive Therapy (ECT) is a procedure indicated for the treatment of several neuropsychiatric conditions, including severe and life-threatening disorders and situations such as depression with risks of suicide or malnutrition, catatonia, refractory schizophrenia, mania with severe psychomotor agitation and status epilepticus. Although this is a life-saving treatment, maintaining the ECT services during the COVID-19 pandemic has become a challenge due to the intrinsic risks of anesthetics and airway management during the procedure. Anesthesia for ECT consists in the use of a short-acting hypnotic agent (propofol, etomidate, or thiopental) followed by a neuromuscular blocker, the most used is succinylcholine due to its rapid onset and offset of action. Oxygen supply is provided through a noninvasive bag and mask ventilation. This is a critical point in the procedure because noninvasive ventilation poses a higher risk of contamination due to aerosol release from contaminated patients. To address this challenge, some services are using a Laryngeal Mask (LMA) for ventilation, others are trying not to ventilate patients during the procedure, using preoxygenation via a non-rebreather mask. The latter can be dangerous because the patient’s oxygen saturation may drop to a level that requires some kind of ventilatory support. Although the procedure is fast enough to allow the use of LMA, the risk of contamination due to the aerosol spray does not decrease significantly; in addition, LMA can induce the patient to cough. In our ECT service, we modified the noninvasive ventilation technique (Fig. 1) by installing a HEPA (High-Efficiency Particulate Arrestance) filter between the bag and the mask to retain the viral particles. Additionally, a sterile plastic bag surrounding the mask and the patient’s face is attached to the ventilatory system. This device protects against the aerosol that may escape from between the mouth and the mask and spread viral particles around the ECT room. The edge of the plastic bag can be fixed with clamps. All ventilatory material is replaced among patients. The use of low O2 flow during ventilation is also a recommended measure. The psychiatrist, anesthesiologist, and nurses should all use personal protective equipment such as a N95 mask, face shield, gloves, and an impermeable gown.
Figure 1

Technique to reduce the risk of contamination from COVID-19 during the ECT procedure.

Technique to reduce the risk of contamination from COVID-19 during the ECT procedure. We believe this is a safe and effective way to reduce the risk of contamination from COVID-19 during the ECT procedure.

Conflicts of interest

The authors declare no conflicts of interest.
  2 in total

1.  Electroconvulsive Therapy During COVID-19: An Essential Medical Procedure-Maintaining Service Viability and Accessibility.

Authors:  Randall T Espinoza; Charles H Kellner; William V McCall
Journal:  J ECT       Date:  2020-06       Impact factor: 3.635

2.  A Strategy for Management of Electroconvulsive Therapy Patients During the COVID-19 Pandemic.

Authors:  Ethan O Bryson; Amy Starr Aloysi
Journal:  J ECT       Date:  2020-09       Impact factor: 3.692

  2 in total
  1 in total

1.  An Online Survey About Electroconvulsive Therapy in Japan During the COVID-19 Pandemic: Comparison of Early and Recent Stages.

Authors:  Risa Hirata; Hirotsugu Kawashima; Takashi Tsuboi; Ken Wada; Minoru Takebayashi; Taro Suwa
Journal:  Neuropsychiatr Dis Treat       Date:  2022-06-28       Impact factor: 2.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.